Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard
Authors:
- Reza AghanouriRAReza Aghanouri
- Mostafa GhaneiMGMostafa Ghanei
- Jafar AslaniJAJafar Aslani
- Hossein Keivani-AmineHKHossein Keivani-Amine
- Ferdos RastegarFRFerdos Rastegar
- Ali KarkhaneAKAli Karkhane
- 1 December 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 287 (6) , L1160-L1164
Abstract
Over 100,000 Iranian war veterans suffer from chronic effects of mustard gas exposure. Sulfur mustard was used by Iraq during the Iraqi-imposed war on Iran (between 1980 and 1988). The major complaints of these patients are mild interstitial fibrosis and bronchiolitis. We aimed to determine the state of fibrosis progression and assessed transforming growth factor (TGF)-β1 levels in pulmonary samples and in bronchoalveolar lavage (BAL) aspirates. A total of 126 war veterans confirmed for lung disease were assessed and compared with three control groups: 1) 64 veterans not exposed to chemical agents, 2) 12 idiopathic pulmonary fibrosis civilian patients, and 3) 33 normal persons. BAL was performed via a flexible fiber-optic bronchoscope and the standard manual method. Total protein was measured by Bradford assay, and samples were corrected with regard to coefficients. Samples were concentrated 15-fold by lyophilization and resolubilization. Samples were double-checked using an ELISA test kit. The Mann-Whitney test was used for the data analysis using commercial software. We detected that significant differences between TGF-β1 levels between the case group and control group 1 ( P = 0.001) and control group 3 ( P = 0.003). No significant differences were found between the case group and control group 2 ( P = 0.57). Inflammation and fibrotic processes in lung tissue of patients exposed to sulfur mustard may be progressive so IFN-γ may be a useful drug to these patients' treatment.Keywords
This publication has 33 references indexed in Scilit:
- Bronchiolitis Obliterans in a Survivor of a Chemical Weapons AttackJAMA, 2003
- Interferon Gamma-1b for the Treatment of Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-??1 GENETransplantation, 1998
- Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lungEuropean Respiratory Journal, 1996
- Molecular Mechanisms of Antifibrotic Effect of Interferon Gamma in Bleomycin-Mouse Model of Lung Fibrosis: Downregulation of TGF-β and Procollagen I and III Gene ExpressionExperimental Lung Research, 1995
- Transforming growth factor beta 1 gene expression in human airways.Thorax, 1994
- Platelet-derived growth factor in idiopathic pulmonary fibrosis.Journal of Clinical Investigation, 1990
- Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosisNature, 1990
- Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis.Thorax, 1986